Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: The science and art of assisted reproductive technologies

Fertility and Sterility

Volumn 80, Issue 5, 2003, Pages 1105-1107

  Kelly, Eduardo ^a  

^a EMD SERONO INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN AGONIST; GONADOTROPIN DERIVATIVE; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT FOLLITROPIN;

CLINICAL PRACTICE; CLINICAL TRIAL; CORRELATION ANALYSIS; DERIVATIZATION; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; EVIDENCE BASED MEDICINE; FEMALE INFERTILITY; HORMONAL REGULATION; HUMAN; INFERTILITY THERAPY; MEDICAL DECISION MAKING; META ANALYSIS; OUTCOMES RESEARCH; OVARY HYPERSTIMULATION; PHARMACEUTICAL ENGINEERING; PRIORITY JOURNAL; SHORT SURVEY; STATISTICAL SIGNIFICANCE;

EID: 0242544019     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(03)02186-1     Document Type: Note

References (21)

1. Laufer N. Assisted hatching - what is the evidence? In: Abstracts of the 3rd World Congress on Controversies in Obstetrics, Gynecology & Infertility. Washington, DC; 2002.
2. Goldfarb JM, Desai N. Follitropin-α versus human menopausal gonadotropin in an in vitro fertilization program. Fertil Steril 2003;80:1094-9.
3. van Wely M, Westergaard LG, Bossuyt PMM, van der Veen F. Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis. Fertil Steril 2003;80:1086-93.
4. Giudice E., Crisci C., Eshkol A., Papoian R. Composition of commercial gonadotrophin preparations extracted from human post-menopausal urine characterization of non-gonadotrophin proteins . Hum Reprod. 9:1994;2291-2299.
5. Giudice E., Crisci C., Altarocca V., O'Brien M. Characterisation of a partially purified human menopausal gonadotropin preparation. J Clin Res. 4:2001;27-33.
6. Cook A.S., Webster B.W., Terranova P.F., Keel B.A. Variation in the biologic and biochemical characteristics of human menopausal gonadotropin. Fertil Steril. 49:1988;704-712.
7. Stone B.A., Quinn K., Quinn P., Vargyas J.M., Marrs R.P. Responses of patients to different lots of human menopausal gonadotropins during controlled ovarian stimulation. Fertil Steril. 52:1989;745-752.
8. Loumaye E., Campbell R., Salat-Baroux J. Human follicle-stimulating hormone produced by recombinant DNA technology a review for clinicians . Hum Reprod Update. 1:1995;188-199.
9. Daya S. Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction. Fertil Steril. 77:2002;711-714.
10. Mohan V. Which insulin to use? Human or animal? Curr Sci. 83:2002;1544-1547.
11. Richter B, Neises G. "Human" insulin versus animal insulin in people with diabetes mellitus (Cochrane Review). In: The Cochrane Library, Issue 3, 2002. Oxford (UK): Update Software, 2002.
12. Collins R., Peto R., Baigent C., Sleight P. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med. 336:1997;847-860.
13. Goldhaber S.Z., Kessler C.M., Heit J.A., Elliott C.G., Friedenberg W.R., Heiselman D.E., et al. Recombinant tissue-type plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism a randomized controlled multicenter trial . J Am Coll Cardiol. 20:1992;24-30.
14. Serhal P., Phopong P., Ranieri D.M. Comparison between human menopausal gonadotrophin and recombinant FSH for ovarian stimulation in patients undergoing in-vitro fertilization. [abstract] Hum Reprod. 15:2000;143.
15. Gordon U.D., Harrison R.F., Fawzy M., Hennelly B., Gordon A.C. A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil Steril. 75:2001;324-331.
16. Ng E.H., Lau E.Y., Yeung W.S., Ho P.C. HMG is as good as recombinant human FSH in terms of oocyte and embryo quality a prospective randomized trial . Hum Reprod. 16:2001;319-325.
17. Strehler E., Abt M., El-Danasouri I., De Santo M., Sterzik K. Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil Steril. 75:2001;332-336.
18. Westergaard L., Erb K., Laursen S.B., Rex S., Rasmussen P.E. Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection a prospective study . Fertil Steril. 76:2001;543-549.
19. Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles a randomized, comparative trial . Fertil Steril. 78:2002;520-528.
20. Oxman A.D., Cook D.J., Guyatt G.H. Users' guides to the medical literature, VI. How to use an overview. JAMA. 272:1994;1367-1371.
21. Daya S., Gunby J., Hughes E.G., Collins J.A., Sagle M.A. Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles a meta-analysis . Fertil Steril. 64:1995;347-354.